Avestria Ventures is a San Francisco-based venture capital firm investing in early-stage women's health and female-led life science companies. Founded in 2018 by Linda Greub and Corinne Nevinny, the firm typically leads rounds with checks of $500K to $5M from pre-seed through Series A.
73% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Their most common stage is series-b (47% of deals). Average disclosed round size is $24.2M (across 14 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Series B
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 May Health | Series B | $11.7M | Jan 2026 |
| MMercy Bio | Series B | $59M | Sep 2025 |
 Mercy BioAnalytics | Series B | $59M | Sep 2025 |
| May Health | Series B | $25M | May 2024 |
 Midi | Series B | — | Apr 2024 |
 Avation Medical | Series C | $22M | Feb 2024 |
| May Health | Unknown | $25M | Jan 2024 |
 Midi Health | Series B | $60M | Jan 2024 |
 Raydiant Oximetry | Series A | $5M | Nov 2021 |
| Raydiant Oximetry | Series B | $5M | Nov 2021 |
| KK2P | Bridge | $3.7M | Dec 2019 |
 Clarified Precision Medicine | Seed | $1.2M | — |
 Novocuff | Series A | $26M | — |
| Avation Medical | Growth | $22M | — |
 Alydia Health | Series C | $13.9M | — |
Top Co-Investors
Bpifrance3 shared
Sofinnova Partners3 shared
Trill Impact3 shared
Operator Collective2 shared
GV2 shared
Icon Ventures2 shared
1843 Capital2 shared
GingerBread Capital2 shared
SemperVirens Venture Capital2 shared
Muse Capital2 shared
Actions Capital2 shared
Able Partners2 shared
Emerson Collective2 shared
Felicis2 shared
Asahi Kasei2 shared
Angelini Ventures2 shared
ShangBay Capital2 shared
JobsOhio2 shared
Medtronic2 shared
Band of Angels2 shared
Last updated: 7 October 2026